Search results
FDA extends review of Ascendis Pharma's hypoparathyroidism drug By Investing.com
Investing.com· 7 hours agoAscendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company, has received notice from the U.S....
US FDA extends review of Ascendis Pharma's hormone disorder therapy
Reuters via AOL· 8 hours agoU.S.-listed shares of the company were down 6.6% in late afternoon trading. The health regulator...
FDA: Avoid These Dairy Products During the Current Bird Flu Outbreak
Prevention· 6 days agoThe FDA reported which dairy products are safe to eat amid the recent bird flu outbreak. Bird flu...
FDA issues ‘most serious type of recall’ involving app-reliant insulin pumps
WPIX New York City, NY via Yahoo News· 16 hours agoThe U.S. Food and Drug Administration has issued a recall correction for an Apple iOS app used with...
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
Reuters via Yahoo News· 3 hours agoThe companies are seeking the Food and Drug Administration's (FDA) approval of a weekly dose of...
FDA: Cue Health COVID tests may return false positive, negative results, so throw them away
Naples Daily News via Yahoo News· 14 hours agoCheck your cabinets. The U.S. Food and Drug Administration (FDA) warned consumers and healthcare...
FDA issues warning to Cue Health over COVID-19 test By Investing.com
Investing.com· 1 day agoCue Health Inc. (NASDAQ:HLTH), a healthcare technology company, has received a warning letter from...
FDA warns some packaged baby food contains potentially toxic metals
WFTV via Yahoo News· 13 hours agoParents with newborn babies may want to listen to this new warning from the U.S. Food and Drug...
FDA Pledges to Ramp Up Fight Against Unauthorized Vapes
Bloomberg· 12 hours agoThe US Food and Drug Administration is stepping up its efforts to combat unauthorized tobacco...
... Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for...
WJET - WFXP Erie· 3 hours agoFood and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: LEQEMBI®) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation ...